• Discusses the clinical and cost effectiveness evidence relating to these guidelines.
I N B R I E F PRACTICE
The National Institute for Health and Clinical Excellence (NICE) has developed a guideline on 'Prophylaxis against infective endocarditis' . This paper details the recommendations from these guidelines which relate to dental practice and discusses the clinical and cost-effectiveness evidence pertaining to them. This is taken from the full NICE guideline, which also in cludes guidance relating to non-dental procedures (www.nice.org.uk/CG064).
BACKGROUND
Infective endocarditis (IE) is a rare condition, with an annual incidence of fewer than 10 per 100,000 cases in the normal population. Despite advances in diagnosis and treatment, IE remains a life-threatening disease with signifi cant mortality and morbidity. 1 It has been accepted clinical practice to use antibiotic prophylaxis prior to dental procedures with the aim of preventing the development of infective endocar ditis in those who are considered to be at risk. The logic for this has been that while many cases of IE are not caused by interventional procedures, 2 there have been cases of infective endocar ditis which have been associated with patients having a prior interventional procedure, notably following dental pro cedures. The rationale for prophylaxis against IE is: infective endocarditis usu ally follows bacteraemia, certain inter ventional procedures cause bacteraemia with organisms that can cause endocar ditis, these bacteria are usually sensi tive to antibiotics; therefore, antibiotics should be given to patients with predis posing heart disease before procedures that may cause bacteraemia. 3 However, while the argument for using prophylaxis has a rational basis, the evi dence base has relied heavily on extrapo lation from animal models of the disease 4 and the applicability of these models to humans has been questioned. The effi cacy of prophylaxis and proof of a link between dental procedures and the development of infective endocarditis has never been firmly demonstrated and clinical practice has been dictated by clinical guidelines based on expert opinion. Recent guide lines by the British Society for Antimi crobial Chemotherapy 5 and the American Heart Association 6 have highlighted the lack of clear evidence in this area and have also challenged existing dogma by highlighting the prevalence of bacterae mias that arise from everyday activities such as tooth brushing.
NICE PROCESS
NICE recommendations are based on systematic reviews of best available evi dence; guideline development groups use consensus techniques to develop recommendations using the avail able evidence. Where there is minimal research evidence, the guideline devel opment group use their opinions about what constitutes best practice.
With a serious rare condition like IE, research using the experimental study designs is difficult and the evidence base consists of observational (predomi nantly case-control) studies.
RECOMMENDATIONS
Healthcare professionals should regard people with the following cardiac con ditions as being at risk of developing infective endocarditis:
• Acquired valvular heart disease with stenosis or regurgitation
• Valve replacement • Structural congenital heart disease, including surgically corrected or palliated structural conditions, but excluding isolated atrial septal defect, fully repaired ventricular septal defect or fully repaired patent ductus arteriosus, and closure devices that are judged to be endothelialised
• Previous infective endocarditis • Hypertrophic cardiomyopathy.
Healthcare professionals should offer people at risk of infective endocarditis clear and consistent information about prevention, including:
• The benefits and risks of antibiotic prophylaxis and an explanation of why antibiotic prophylaxis is no longer routinely recommended
• The importance of maintaining good oral health
• Symptoms that may indicate infective dental procedures. [9] [10] [11] [12] [13] [14] [15] It was also noted to undertake a de novo analysis. A very endocarditis and when to seek that cases of infective endocarditis have simple model was developed to explore expert advice
• The risks of undergoing invasive procedures, including non-medical procedures such as body piercing or tattooing.
Antibiotic prophylaxis against infec tive endocarditis is not recommended for people undergoing dental procedures.
Chlorhexidine mouthwash should not be offered as prophylaxis against infec tive endocarditis to people at risk of infective endocarditis undergoing den tal procedures.
Any episodes of infection in people at risk of infective endocarditis should be investigated and treated promptly to reduce the risk of endocarditis developing.
EVALUATION OF THE EVIDENCE ON CLINICAL EFFECTIVENESS
This section includes a brief summary of the relevant clinical effectiveness evi dence; for the full evaluation see the NICE guideline (www.nice.org.uk/CG064).
Consideration of the evidence on dental procedures and the development of infec tive endocarditis identifi ed that there is an inconsistent association between recent dental interventional procedures and infective endocarditis. This can be exemplified with one study noting that endocarditis due to α-haemolytic strep tococci in those with native valve endo carditis appeared to be associated with known heart disease, natural dentition and recent dental procedures (endocardi tis occurred 4.9 times more often in those with all three of these factors compared with those without any), 7 while a case control study identified that any dental procedure (including dental extraction) showed no increased risk with cases compared with controls. 8 Studies which considered bacteraemia related to dental procedures (usually at one or two time points following the procedures) identified bacteraemia fol lowing many dental procedures (though, in a number of studies bacteraemia was also identified prior to procedures). How ever, studies which also considered tooth brushing also identifi ed bacteraemia, often considered to be to be of similar or greater intensity to that found following been documented which have arisen following dental procedures for which antibiotic prophylaxis had been given. 7 It was concluded that it was biologically implausible that a single dental procedure would lead to a greater risk of infective endocarditis than regular tooth brushing. Appropriate and prompt antibiotic treat ment of oral infections is recommended, since when an oral or tissue infection is present it was considered that repetitive, or continuous bacteraemias from the site would be occurring. Also, if an antibiotic is being prescribed this would cover the oral flora involved and therefore cover any potential infective endocarditis caus ing organisms form this site.
EVALUATION OF THE EVIDENCE ON COST-EFFECTIVENESS
This section includes a brief summary of the relevant cost-effectiveness evi dence; for the full evaluation see the NICE guideline.
Published health economics literature
A literature review was conducted to identify cost-effectiveness evidence on antimicrobial prophylaxis against IE in individuals with a predisposing cardiac condition undergoing interventional procedures. A total of five relevant stud ies were identified that considered both costs and outcomes. [16] [17] [18] [19] [20] These studies provided contradictory evidence on the cost-effectiveness of antibiotic prophy laxis for at-risk patients undergoing interventional procedures. However, it has been commonly observed that peni cillin could result in many more deaths (at least in the short term) secondary to anaphylaxis compared with a strategy of no prophylaxis. In addition, the cost effectiveness of antibiotic prophylaxis appears to also critically depend on the baseline risk of developing IE. It is not apparent if any of the economic evalu ations took into account the recurring risk of IE and the additional future costs of antibiotic prophylaxis.
De novo economic evaluation
Given the lack of up-to-date, UK-rel evant analyses, it was considered useful the cost-effectiveness of antibiotic prophylaxis for infective endocarditis in adults with predisposing cardiac condi tions undergoing dental procedures.
In the model, nine antibiotic prophy laxis options were compared against a strategy of no antibiotic prophylaxis. The prophylactic options explored were those set out in the British National For mulary 54th edition (BNF 54) because they represent current UK practice at the time the guideline was developed. All antibiotic strategies were assumed to be of equal effectiveness. Full details of the process are available in the appendices of the full NICE guideline (www.nice. org.uk/CG064).
The model suggests that prophy lactic antibiotic strategies are highly cost-ineffective under all scenarios explored in the present analysis unless highly optimistic assumptions are made with regard to a number of parameters, chiefly the risk of developing IE fol lowing a dental procedure. Even when optimistic assumptions are made with regard to antibiotic efficacy and the risk of developing IE following a den tal procedure, the risk of antibiotic side effects (particularly with respect to amoxicillin-containing strategies) can potentially increase the incremental cost-effectiveness ratios markedly and even lead to greater deaths through fatal anaphylaxis than a strategy of no anti biotic prophylaxis.
CONCLUSION
In summary, this guideline recommends that antibiotic prophylaxis to prevent IE should not be given to people at risk of IE undergoing dental procedures. The basis to support this recommendation is:
• There is no consistent association between having an interventional procedure, dental or non-dental, and the development of IE
• Regular tooth brushing almost certainly presents a greater risk of IE than a single dental procedure because of repetitive exposure to bacteraemia with oral fl ora 
